Grail's stock surged 55% in one week following a positive FDA advisory committee vote on its Galleri multi-cancer early detection test, which was deemed safe and beneficial. Analyst Kyle Mikson raised the price target from $80 to $150, reflecting strong confidence in the company's future and an 18.21% potential upside from the current trading price of $126.89. This FDA advisory vote is a key step toward potential premarket approval, marking a significant regulatory milestone for Grail's innovative cancer detection technology.
Grail's stock price target was recently raised to $150, indicating strong confidence in its future prospects. For readers following the health sector, here is Pluang's market snapshot as of Sep 28, 2026 19:53 WIB: out of 100 priced health-sector US stocks, 23 rose and 64 fell today. Notable movers include MESO at USD 14.59 with a -3.51% change and a typical hold time of 13 days, MRNA at USD 193.75 down 2.58% with a 60-day hold time, and CLPT at USD 14.49 down 2.29% with a 10-day hold time.
Tiziana Life Sciences has dosed the first three patients in a Phase 2a trial testing foralumab, a nasal spray antibody, for treating early-stage ALS. The Healey ALS MyMatch BANYAN trial will enroll 44 patients to evaluate safety, tolerability, and im...
1911 Gold Corp released its first sustainability report for the True North Gold Project, showing zero environmental incidents and regulatory fines in 2025. The report highlights the company's commitment to safe, responsible operations and strong comm...
Reconnaissance Energy Africa's flow test samples from the Kavango West 1X Sidetrack well in Namibia indicate a thermogenic gas system with liquid potential, showing maturities from late oil to early gas. The company plans a horizontal test to confirm...
Qualcomm has renewed its Global Patent License Agreement with Apple, removing a major uncertainty for investors. The stock trades near $194 with a 24/7 Wall St. price target of $228.68, implying a 16.27% upside. Qualcomm's growth is driven by expandi...
McDonald's, the world's largest quick-service restaurant chain, has increased its dividend for 51 consecutive years, earning it the status of Dividend Aristocrat and Dividend King. The company has a solid financial position with an interest coverage ...
